Navigation Links
Comparing Psoriasis Treatments

A new study shows two common treatments for psoriasis -- methotrexate and cyclosporine -- are equally effective in relieving symptoms of the disease. //

Researchers in Amsterdam studied nearly 90 patients with moderate-to-severe psoriasis. Half of the patients were given methotrexate, and the other half were treated with cyclosporine. Researchers evaluated the side effects and effectiveness of each drug. They also recorded the time patients were in remission and assessed their quality of life. None of the participants had previously been treated with methotrexate or cyclosporine.

Results of the study show the overall response rate for both drugs was more than 90 percent. Seventeen patients in the methotrexate group and 14 patients in the cyclosporine group reached nearly complete remission. Twenty-six patients in the methotrexate group and 30 patients in the cyclosporine group achieved partial remission. However, after 16 weeks of treatment, no significant difference in overall effectiveness was seen between the two groups.

More than 100 patients in the methotrexate group and more than 150 patients in the cyclosporine group reported side effects. More patients in the methotrexate group reported nausea, and patients in the cyclosporine group were more likely to report headaches. There were no significant reported differences in quality of life between the two groups.

Authors of the study say the overall effectiveness of methotrexate is similar to that of cyclosporine. They conclude, "Differences between the treatments in terms of side effects, long-term adverse effects, ease of administration, and costs can be used to guide treatment decisions in individual cases."
'"/>




Page: 1

Related medicine news :

1. Comparing Breast surgery techniques
2. Comparing heart disease treatments
3. New and unique treatment for Psoriasis patients
4. Psoriasis Increases Cancer Risk
5. Help for Psoriasis
6. Managing Patients With Psoriasis
7. Effective Treatment Option For Psoriasis
8. Smoking Aggravates Psoriasis
9. Remicade Emerges as a Treatment for Patients Suffering From Psoriasis Disorder
10. Short-Term Topical Corticosteroid May Offer Relief for Certain Type of Psoriasis
11. Psoriasis raises risk for heart attack
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare ... Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during ... , The annual award competition recognizes editorial and design excellence across a range of ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & Wellness ... Moonlight to raise money for the American Heart Association Heart Walk. Teams of up ... work together to keep their treadmills moving for 5 hours. Treadmills will start at ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... CHICAGO , Sept. 28, 2017 Hill-Rom ... quarter 2017 earnings conference call and webcast on Friday, ... 8:00 a.m. (EDT) and ending at approximately 8:30 a.m. ... to discussing the company,s 2017 financial performance and guidance ... growth opportunities, initiatives to enhance operational performance, and long-range ...
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
Breaking Medicine Technology: